Acamprosate: recent findings and future research directions - Wikidata - awgldk - TriplyDB

Acamprosate: recent findings and future research directions

Acamprosate: recent findings and future research directions

http://www.wikidata.org/entity/Q28283210

about

Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior Acamprosate for alcohol dependence Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate Using glutamate homeostasis as a target for treating addictive disorders Long-term drug treatment of patients with alcohol dependence Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinence Emerging pharmacologic treatment options for fragile X syndrome The development of acamprosate as a treatment against alcohol relapse Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence.Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care Glutamatergic transmission in drug reward: implications for drug addiction Acamprosate: A Review of Its Use in Alcohol Dependence Acamprosate produces its anti-relapse effects via calcium Pharmacotherapies for Overeating and Obesity.Potential therapeutic interventions for fragile X syndrome Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management.Molecular fingerprinting of principal neurons in the rodent hippocampus: A neuroinformatics approach.Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.Acamprosate.Pharmacological strategies for detoxification.Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction Getting a grip on problem gambling: what can neuroscience tell us?Fragile X targeted pharmacotherapy: lessons learned and future directions.Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1 Comparison of healthcare utilization among patients treated with alcoholism medications.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker.Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.Six-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study.Acamprosate-responsive brain sites for suppression of ethanol intake and preference Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawal An open-label naturalistic pilot study of acamprosate in youth with autistic disorder.Pharmacotherapy of alcohol use disorders: seventy-five years of progress Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment.Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility.An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate.Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression Glutamatergic transmission in the central nucleus of the amygdala is selectively altered in Marchigian Sardinian alcohol-preferring rats: Alcohol and CRF effects

P2860

Q22241964-EE90FA6B-B556-4CAC-9834-B1E1C9B9CA60 Q24235594-35499D1E-22A9-4044-89CF-ECB8BC4D8A23 Q24336813-66364661-0D11-4E12-8210-C580EF0585B1 Q24619198-EA779282-0688-4C58-804C-88328ED3B316 Q26773332-3C2186A0-090D-4C4A-99DE-9B4EF0EC46EA Q26781265-43CC1AB4-87F8-45C2-9B29-7FFC8061FB2B Q26801196-CAD20850-E9B8-4135-A067-5315E0409F7D Q26829152-A5DB64B6-1A9F-443D-84F1-B33C7439C890 Q26862199-CB2C08D4-E96D-4384-9DEF-B2BF1FCDF401 Q26995739-F2D1DB34-990F-40A5-96DF-4A1F156842C2 Q28081029-03225EE8-3C54-47D1-A9C4-7F90221D9B61 Q28112161-B3AA7A75-CA2B-4CEB-BF52-D55D0B439673 Q28263633-4A2AED57-C340-400E-913B-4470F223D384 Q28299533-1F604853-13E2-49E7-B4DB-14A44B2AE97E Q30351879-6D2917CA-62BA-4A70-B7BD-DA281F6468BD Q30473378-D4546650-084C-4944-8D7D-7EC6DB78D89E Q30480531-1BE829D6-40BC-4940-8A1F-1CC6A88DEA04 Q30491801-2A1DB099-66CF-4914-BC96-EF4445026296 Q30751889-4A2F518A-E3A8-48A6-A37E-F306148C62A4 Q33531891-ECE3C100-BF45-4F6E-BFB7-239B7638CB4F Q33582092-D0D3D1AB-EE14-4E97-8E25-4C831E9F7ADE Q33626978-3D724E7C-A935-40C2-95AD-59DCBE0194BE Q33658552-A4B072D6-6A6F-4E5F-9C31-731E1563FE00 Q33785983-CB7C8D93-F92C-4E4D-A4E7-0BD22EC563B1 Q34018001-D77D05EA-CCFB-4E68-8A6F-199D4302AD34 Q34155813-95764C26-8122-45CA-8053-324A7AD21C4B Q34162896-4700BB75-2A31-4A41-A940-4D3D8D69D5ED Q34277168-45504BB4-A92B-48AC-AD0D-04B850EEFFCA Q34620558-0812A6E2-D086-4A4A-94E5-39EE3054C3A3 Q34711313-5111365D-1233-466E-8CEE-B708E5F057A6 Q34773574-17A1C819-E5E8-498D-9FA1-E0A15257351A Q35395058-86DD2B5A-4C51-47BC-BF58-B87C791338E4 Q35589974-DFF2F876-5C17-418D-BF89-1E3384EA43F9 Q35625886-80CCDB80-28C7-454D-A94E-549879D7A256 Q35677411-DD910B6B-DEAD-4044-8D33-71A9DC079E4B Q35696834-9B560489-72A6-475C-B09D-F8DD5C59BBD9 Q35752035-2D85E1F3-6904-456A-B1FD-7DA5AD1EFE19 Q36145548-741FAAC8-2D17-4E82-BB66-23C040E3EDB9 Q36417179-E9B02C51-C65B-498E-98CC-B20E0FCCFB63 Q36421960-491AAEC6-9676-4FC9-BD44-569C56C663A3

P2860

Acamprosate: recent findings and future research directions

http://www.wikidata.org/entity/Q28283210

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Acamprosate: recent findings and future research directions

@ast

Acamprosate: recent findings and future research directions

@en

Acamprosate: recent findings and future research directions

@nl

type

label

Acamprosate: recent findings and future research directions

@ast

Acamprosate: recent findings and future research directions

@en

Acamprosate: recent findings and future research directions

@nl

prefLabel

Acamprosate: recent findings and future research directions

@ast

Acamprosate: recent findings and future research directions

@en

Acamprosate: recent findings and future research directions

@nl

P1433

Q28283210-A7D42900-D1C4-404C-B8ED-BCCF605BE9C0

P1476

Q28283210-F7617209-ABC2-4079-8FB8-2EFB4FABCC5A

P2093

Q28283210-7011DBC6-E75D-4962-B5C3-50DED368B19D

Q28283210-956EE2D3-4735-4933-89BB-92C7569FC9FE

Q28283210-AC83777B-4711-40AA-8D8E-3F24520578E5

Q28283210-BB80E1B4-EEC8-4A05-BC3B-91B0A0B8FD1F

P2860

Q28283210-23AF5ECA-3516-4AD6-9620-C260B1929D46

Q28283210-4D3B0099-7873-4EE3-976B-B4F9FA8484BF

Q28283210-5999CC4D-524F-4685-A1BB-88679E651481

Q28283210-9CDA4E54-7E82-4239-836B-070E134A77A6

Q28283210-E86BE723-6252-47C7-B9A8-A52A22574221

P304

Q28283210-9861879C-1E90-47DC-87FD-181111BBB33C

P31

Q28283210-FC9F8538-8AEA-40F0-8406-8D335349EC35

P356

Q28283210-80A8084B-9AE1-4D65-8616-E944B25C6D82

P407

Q28283210-99704FCE-B739-43A5-81CD-D2B99D1D19DE

P433

Q28283210-3E45C6D0-6A56-4EF2-AF5E-43BF87A98C1D

P478

Q28283210-DDE147F7-CAA9-4751-A707-CC4E8AC16B45

P577

Q28283210-E8F73D11-856B-4066-90B0-75038A672732

P5875

Q28283210-C8313FC7-851D-4C70-B33B-86FFFB9F2324

P698

Q28283210-77D599C6-B32A-40D8-A7AD-B9BB95B429C1

P356

J.1530-0277.2008.00690.X

P1433

Alcoholism: Clinical and Experimental Research

P1476

Acamprosate: recent findings and future research directions

@en

P2093

Falk Kiefer

http://www.w3.org/2001/XMLSchema#string

John Littleton

http://www.w3.org/2001/XMLSchema#string

Karl Mann

http://www.w3.org/2001/XMLSchema#string

Rainer Spanagel

http://www.w3.org/2001/XMLSchema#string

P2860

A three-pathway psychobiological model of craving for alcohol.

Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.

Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors.

Drugs for relapse prevention of alcoholism: ten years of progress.

Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain.

P304

1105-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1530-0277.2008.00690.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5316370

http://www.w3.org/2001/XMLSchema#string

P698

18540918

http://www.w3.org/2001/XMLSchema#string